S. Rodda

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

William Morris, Scott Tyldesley, S. Rodda et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 714 citations

Urology, Radiation Therapy, Medicine +8

ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

S. Rodda, Scott Tyldesley, William Morris et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 303 citations

Urology, Radiation Therapy, Low-dose-rate Brachytherapy Boost +7

ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

S. Rodda, William Morris, Jeremy Hamm et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 98 citations

Quality Of Life, Urology, Health Sciences +9

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Chris Parker, Howard Kynaston, Adrian Cook et al. · The Lancet · 2024 · 65 citations · Full text

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 43 citations · Full text